Mokari Atabak — SEC Form 4 filings
SEC reporting owner CIK 1678419. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-13 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 22 legs across 4 filings — 200,000 shares, $18,731,290 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
- Largest priced transaction: sale of 40,000 shares @ $70.00 ($2,800,004) in CORCEPT THERAPEUTICS INC, filed 2026-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CORCEPT THERAPEUTICS INC (CORT) | Chief Financial Officer | 16 | — | 22 legs · 200,000 sh · $18,731,290 | 46 |
Form 4 filings — Mokari Atabak
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 138 @ $113.38 · Grant/award (A): 138 @ $0 · Tax withholding (F): 102 @ $113.38 | EDGAR |
| 2026-08-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 80,000 @ $23.06 · Sale (S): 4,200 @ $105.54 · Sale (S): 8,956 @ $106.96 · Sale (S): 400 @ $108.46 · Sale (S): 2,202 @ $110.03 · Sale (S): 600 @ $110.95 · +9 more | EDGAR |
| 2026-07-17 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 15,833 @ $19.26 · Option exercise (M): 24,167 @ $23.06 · Sale (S): 7,919 @ $86.78 · Sale (S): 28,460 @ $87.89 · Sale (S): 3,520 @ $88.30 · Sale (S): 101 @ $89.43 · +2 more | EDGAR |
| 2026-06-17 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 40,000 @ $19.26 · Sale (S): 9,434 @ $80.02 · Sale (S): 11,081 @ $80.94 · Sale (S): 19,483 @ $81.81 · Sale (S): 2 @ $82.45 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 40,000 @ $19.26 · Sale (S): 40,000 @ $70.00 · Grant/award (A): 634 @ $70.44 · Grant/award (A): 634 @ $0 · Tax withholding (F): 395 @ $70.44 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 397 @ $35.97 · Grant/award (A): 397 @ $0 · Tax withholding (F): 96 @ $35.97 | EDGAR |
| 2026-03-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 178 @ $79.78 · Grant/award (A): 178 @ $0 · Tax withholding (F): 118 @ $79.78 | EDGAR |
| 2025-09-04 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 200 @ $71.38 · Grant/award (A): 200 @ $0 · Tax withholding (F): 144 @ $71.38 | EDGAR |
| 2025-06-04 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 775 @ $71.68 · Grant/award (A): 775 @ $0 · Tax withholding (F): 519 @ $71.68 | EDGAR |
| 2025-03-04 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Tax withholding (F): 228 @ $60.58 · Grant/award (A): 232 @ $59.07 · Grant/award (A): 232 @ $0 · Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Tax withholding (F): 182 @ $57.68 · Grant/award (A): 231 @ $59.21 · Grant/award (A): 231 @ $0 | EDGAR |
| 2024-09-05 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Tax withholding (F): 143 @ $35.30 · Grant/award (A): 400 @ $34.26 · Grant/award (A): 400 @ $0 | EDGAR |
| 2024-06-05 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Tax withholding (F): 571 @ $30.17 · Grant/award (A): 1,448 @ $31.30 · Grant/award (A): 1,448 @ $0 | EDGAR |
| 2024-03-05 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Tax withholding (F): 517 @ $24.06 · Grant/award (A): 554 @ $24.06 · Grant/award (A): 554 @ $0 | EDGAR |
| 2024-02-13 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1678419 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →